日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Extent and Incidence of Pseudo-Worsening of Kidney Function Due to Oral Antitumor Therapeutics in the AMBORA Cohort: An Analysis of Real-World Data

AMBORA队列中口服抗肿瘤药物引起肾功能假性恶化的程度和发生率:一项基于真实世界数据的分析

Sponfeldner, Michael I; Dürr, Pauline; Lensker, Phyllis; Gessner, Katja; Cuba, Lisa; Fietkau, Rainer; Neurath, Markus F; Wullich, Bernd; Pavel, Marianne; Berking, Carola; Beckmann, Matthias W; Mackensen, Andreas; Dörje, Frank; Fromm, Martin F

Targeting PI3K inhibitor resistance in breast cancer with metabolic drugs.

利用代谢药物靶向治疗乳腺癌中的PI3K抑制剂耐药性

Gremke Niklas, Besong Isabelle, Stroh Alina, von Wichert Luise, Witt Marie, Elmshäuser Sabrina, Wanzel Michael, Fromm Martin F, Taudte R Verena, Schmatloch Sabine, Karn Thomas, Reinisch Mattea, Hirmas Nader, Loibl Sibylle, Wündisch Thomas, Litmeyer Anne-Sophie, Jank Paul, Denkert Carsten, Griewing Sebastian, Wagner Uwe, Stiewe Thorsten

Pseudo-Worsening of Kidney Function

肾功能假性恶化

Fromm, Martin F; Sponfeldner, Michael I; Dörje, Frank; Gessner, Katja; Dürr, Pauline; Cuba, Lisa; Schwanfelder, Julia

Artificial intelligence-powered chatbots in search engines: a cross-sectional study on the quality and risks of drug information for patients

搜索引擎中人工智能聊天机器人:一项关于药物信息质量和风险的横断面研究

Andrikyan, Wahram; Sametinger, Sophie Marie; Kosfeld, Frithjof; Jung-Poppe, Lea; Fromm, Martin F; Maas, Renke; Nicolaus, Hagen F

New Biomarkers for Renal Transporter-Mediated Drug-Drug Interactions: Metabolomic Effects of Cimetidine, Probenecid, Verapamil, and Rifampin in Humans

肾脏转运蛋白介导的药物相互作用的新生物标志物:西咪替丁、丙磺舒、维拉帕米和利福平在人体内的代谢组学效应

Gessner, Arne; König, Jörg; Wenisch, Pia; Heinrich, Markus R; Stopfer, Peter; Fromm, Martin F; Müller, Fabian

Clinical-pharmaceutical assessment of medication CDSS alerts: content appropriateness and patient relevance in clinical practice

临床药学对药物临床决策支持系统(CDSS)警报的评估:内容适宜性和与临床实践中患者的相关性

Bauer, Jacqueline; Busse, Marika; Koch, Sonja; Schmid, Marina; Sommer, Julia; Fromm, Martin F; Dörje, Frank

Putative new biomarkers for renal transporter-mediated drug-drug interactions: Characterization as substrates of organic cation transporter 2, multidrug and toxin extrusion protein 1, and other important drug transporters

肾脏转运蛋白介导的药物相互作用的潜在新生物标志物:作为有机阳离子转运蛋白2、多药和毒素外排蛋白1及其他重要药物转运蛋白的底物进行表征

Gessner, Arne; Picurová, Jana; Englhard, Lea; Müller, Fabian; Fromm, Martin F; König, Jörg

Metabolomic and immunophenotypic signatures in cerebral amyloid angiopathy: a pilot study

脑淀粉样血管病代谢组学和免疫表型特征:一项初步研究

Tsaktanis, Thanos; Gessner, Arne; Pfeuffer, Steffen; Farrenkopf, Daniel; Naumann, Ulrike J; Fröhlich, Kilian; Sembill, Jochen A; Fromm, Martin F; Schwab, Stefan; Rothhammer, Veit; Kuramatsu, Joji B; Mrochen, Anne

Implications for medication safety and adherence in dermato-oncology: The AMBORA care program for oral antitumor therapeutics

对皮肤肿瘤药物安全性和依从性的影响:口服抗肿瘤药物的AMBORA护理计划

Cuba, Lisa; Dörje, Frank; Kramer, Rafaela; Dürr, Pauline; Erdmann, Michael; Fromm, Martin F; Berking, Carola; Gessner, Katja

Physicians' and pharmacists' perspective on clarity and clinical relevance of absolute contraindications in "Summaries of Product Characteristics"

医生和药剂师对“产品特性概要”中绝对禁忌症的清晰度和临床相关性的看法

Andrikyan, Wahram; Sponfeldner, Michael I; Jung-Poppe, Lea; Dürr, Pauline; Straubmeier, Melanie I; Schuster, Anna K; Weisbach, Laura; Farker, Katrin; Hartmann, Michael; Fromm, Martin F; Maas, Renke